How to Buy Cronos (CRON) Stock

Want to claim 6 FREE stocks? Head over to Webull to get started.

Still blooming and pulling all the stops to attract new investors, the Canadian cannabis company Cronos Group (NASDAQ: CRON), continues to gain traction for multiple reasons. A recent flurry of legislative activity that makes federal cannabis legislation a likely reality and a move toward releasing lab-grown cannabis stocks gives (NASDAQ: CRON) a favorable outlook. The financial tides favor Cronos and investing in the stock can strengthen your portfolio.      

Cronos Group (NASDAQ:CRON)

2.880

-0.16 [-5.26%]
2.87 – 3.05
2.57 – 9.12
3.03
375.58M
98.50K/2.09M
1.08B
375.58M
/0%
0.000
197.16M

How to Buy Cronos Stock

Check out Benzinga’s step-by-step guide to help you buy Cronos stock. 

Pick a Brokerage

Online brokers let you trade stocks, exchange-traded funds (ETFs), mutual funds, forex and more. You can get the latest financial news, historical performance records and crucial stock information on these platforms. 

We’ve handpicked the best online brokers to get you started. 

get started securely through Webull’s website
Best For
Intermediate Traders and Investors
N/A
1 Minute Review

Webull, founded in 2017, is a mobile app-based brokerage that features commission-free stock and exchange-traded fund (ETF) trading. It’s regulated by the Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA).

Webull offers active traders technical indicators, economic calendars, ratings from research agencies, margin trading and short-selling. Webull’s trading platform is designed for intermediate and experienced traders, although beginning traders can also benefit.

Webull is widely considered one of the best Robinhood alternatives.

Best For
  • Active traders
  • Intermediate traders
  • Advanced traders
Pros
  • No account maintenance fees or software platform fees
  • No charges to open and maintain an account
  • Intuitive trading platform with technical and fundamental analysis tools
Cons
  • Does not support trading in mutual funds, bonds or OTC stocks
get started securely through Moomoo’s website
Best For
Active Traders
N/A
1 Minute Review

Moomoo is a commission-free mobile trading app available on Apple, Google and Windows devices. A subsidiary of Futu Holdings Ltd., it’s backed by venture capital affiliates of Matrix, Sequoia, and Tencent (NASDAQ: FUTU). Securities offered by Futu Inc., regulated by the Securities and Exchange Commission (SEC) and the Financial Industry Regulatory Authority (FINRA).

Moomoo is another great alternative for Robinhood. This is an outstanding trading platform if you want to dive deep into smart trading. It offers impressive trading tools and opportunities for both new and advanced traders, including advanced charting, pre and post-market trading, international trading, research and analysis tools, and most popular of all, free Level 2 quotes.

Get started right away by downloading Moomoo to your phone, tablet or another mobile device.

Best For
  • Cost-conscious traders
  • Active and Advanced traders
Pros
  • Over 8,000 different stocks that can be sold short
  • Access trading and quotes in pre-market (4 a.m. to 9:30 a.m. ET) and post-market hours (4 p.m. to 8 p.m. ET)
  • No minimum deposit to open an account.
Cons
  • No chat support
get started securely through Interactive Broker’s website
Best For
GlobalAnalyst Product
N/A
1 Minute Review

This latest groundbreaking technology is IBKR GlobalAnalyst, a new trading tool that helps investors compare the rate of PEG or price-earnings growth valuations and provide more immediate and comprehensive financial metrics of stocks, globally.

Recognizing that stock selection can be challenging for investors to compare the valuations of domestic and international stocks, Interactive Brokers created GlobalAnalyst to offer investors a simple, yet powerful tool to easily evaluate investment opportunities around the world.

Using GlobalAnalyst, investors can search for stocks by region, country, industry, market capitalization and currency to uncover undervalued stocks worldwide. The resulting table displays the current market and financial metrics, including the PEG Ratio. The PEG Ratio is the PE ratio divided by the three-year compound earnings growth rate, and smaller PEG Ratios typically indicate undervalued companies.

Best For
  • Price earnings growth valuations
Pros
  • Easily evaluate investment opportunities
Cons
get started securely through CenterPoint Securities’s website
Best For
Momentum traders
N/A
1 Minute Review

CenterPoint Securities is ideal for active traders who demand access to advanced tools and services. While investors and casual traders are likely to be content with the basic offerings of traditional online brokerages, active traders will benefit from CenterPoint’s suite of advanced trading tools. If you value execution quality, access to short inventory, advanced trading platforms, and accessible customer service, CenterPoint is an excellent choice.

Best For
  • Intermediate to Advanced traders
  • High-volume traders
  • Momentum traders
  • Short sellers
Pros
  • Unrivaled access to short inventory
  • Flexible order routing for improved executions
  • Discounts for active traders
  • Advanced platform with fast executions
  • Reliable customer service
Cons
  • Not designed for beginner or low-volume traders

Decide How Many Shares You Want

You can choose the number of shares to purchase based on your financial needs. Once you have a set amount of money put aside for the investment, divide that amount by the stock price to get the exact number of shares you would like to buy.   

Let’s say you have $100 set aside for Cronos. At $6 per share, you can buy up to 16 shares at a time. 

Choose Your Order Type

Learn these order types before you execute a trade. 

Bid

The bid is the price at which you are willing to buy the shares. If Cronos trades at $6, you can set the bid price to $5.50 and the trade will execute if the stock price drops by $0.50. 

Ask

The ask is the price at which you are willing to sell your shares. If Cronos is trading at $6, you can set the ask price to $6.50 and the trade will execute if the stock price rises by $0.50.  

Spread

The spread is the difference between the bid and ask price of a stock. If Cronos trades at a bid price of $5.50 and an ask price of $6.50, the spread is $1. 

Limit Order

A limit order lets you set a specific price for your trade. If the online broker is unable to find a buyer or seller who wants to trade at your specified price, the trade will not execute. This way, you can trade the stock at the price you want.   

Market Order

You can buy or sell shares at the strike quote of the stock with a market order. The strike quote of the stock depends on the market and not on individual buyers and sellers. It’s the fastest method of trading but you may not trade shares at your desired price. 

Stop-Loss Order

You can cut your losses by executing a stop-loss order for your trades. If you set the stop value at $5, your shares will sell as soon as the stock quote drops to that price. 

Stop-Limit Order

A stop-limit order combines stop and a limit order. You must assign 2 values for a stop-limit order. If Cronos trades at $6, you can assign the stop value to $5 and assign a limit value of $4. As soon as the strike price of Cronos drops to $4, your trade will turn into a sell market order immediately. 

Execute Your Trade

Once you have decided on the order type and the number of shares you want to buy or sell, you can execute your order to have them fulfilled. 

Cronos Stock History

Founded in 2012, Cronos Group is a global cannabinoid (CBD) company with several high-end cannabis brands under its umbrella.

In 2019, the tobacco company Altria (NYSE: MO) became the largest shareholder in Cronos. The multibillion-dollar deal made Altria the majority stakeholder with a 45% equity in the CBD stock. The low cost of Cronos and Altria’s backing has made it one of the safest stocks under $20 to invest in. 

Cronos Executive Chairman Mike Gorenstein recently announced that the cannabis group will create lab-grown cannabis products using biosynthesis. This move bumped CRON up as one of the major biotech stocks to watch.

In 2019, the tobacco company Altria (NYSE: MO) became the largest shareholder in Cronos. The multibillion-dollar deal made Altria the majority stakeholder with a 45% equity in the CBD stock. The low cost of Cronos and its potential for growth could make it one of the best stocks under $20 for your portfolio. 

Pros to Buying Cronos Stock

Take a look at some of the benefits of investing in Cronos. 

1. Legalization pushes

Many states in the United States have legalized medicinal or recreational marijuana in 2021. But cannabinoids are still illegal federally. However, a recent push from senators Chuck Schumer, Cory Booker and Ron Wyden prioritizes the federal legalization of marijuana. They plan to introduce a legistliative package soon meant to reach this goal by the end of 2021.

This renewed legislative attention, plus mostly positive public support for full cannabis legalization, means cannabinoid companies may soon see the legal barriers holding them back from explosive growth removed.

2. Strong, positive cash flow

Cronos delivers its cannabis products directly to consumers and operates a cash-based business that generates millions in revenue.

The cannabis stock has a quarterly cash burn rate of about $43 million. Cronos can run its operations in full swing for another 11.5 years.  

3. Global CBD stock presence

A company with a global footprint, Cronos has a worldwide network of partnerships, joint ventures, production and distribution across 5 continents.  

Headquartered in Toronto, Cronos has a corporate office and client care facility in Canada’s economic epicenter. Its Redwood brand is focuses on the U.S. market. Cronos has a research center, cannabis nursery, greenhouse and manufacturing facility in Israel. It also distributes its CBD products to Australia, Colombia, Germany and Poland. 

4. Strategic decisions

Cronos made huge investments in 2019 and its financial impact is yet to be completely realized. Cronos opened a brand new research center, Cronos Device Labs, in Israel, primarily focused on developing vaporizer products designed for CBD. 

The cannabis company acquired 84,000 square feet of fermentation and manufacturing facility in Winnipeg, Canada. Cronos also acquired 4 Redhood Holding Group, LLC subsidiaries to expand its presence in the U.S.   

5. High liquidity

The CBD company trades an average of 6.5 million shares per day. The high liquidity of the stock makes it a good investment. You can find buyers and sellers of Cronos shares in the market. 

Cons to Buying Cronos Stock

Take a look at some of the drawbacks of investing in Cronos. 

The sale of marijuana is prohibited in most countries around the globe. Its use and possession are still illegal in many states in the U.S. The medicinal use of marijuana is legal in 34 states and recreational use is legal in 11 states. These restrictive policies have severely staggered exponential growth opportunities for Cronos. 

2. Cronos does not pay dividends. 

If you’re looking at long-term investments, you might want to park your money with a CBD stock that pays regular dividends to its shareholders. 

Innovative Industrial Properties Inc. (NYSE: IIPR) is a real estate investment trust (REIT) that has invested in cannabis-producing facilities in the U.S. It has an annual dividend yield of 2.34%. Scott Miracle-Gro (NYSE: SMG) manufactures and sells cannabis growing equipment. It has an annual dividend yield of 1.05%. Cronos has no plans to issue dividends in the near future.  

Right Time to Invest in Cronos?

In less than 9 years, Cronos has made a name for itself in the cannabis industry. Its high-quality products are widely used by customers for medical and recreational needs. With its recent foray into biosynthesizing cannabis and the moves toward federal cannabis legalization, it’s a stock to keep an eye on. You can consider investing in Cronos to elevate your stock portfolio with higher earnings.